Prevalência global, regional e nacional e fatores de risco para doença pulmonar obstrutiva crônica.

Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis – The Lancet Respiratory Medicine

Comentário no Twitter

NEW Research—LMICs account for more than 3/4 of global #COPD cases. W/ increased life expectancy in the majority of LMICs, prevalence of COPD in these countries is set to increase.

Study from NIHR @RESPIREGlobal Respiratory Health Unit https://t.co/KD1OSHuMAr pic.twitter.com/Mfm1uJ2tBm

— The Lancet Respiratory Medicine (@LancetRespirMed) March 11, 2022